Brainsway (BWAY) has released an update.
BrainsWay Ltd., a leader in noninvasive neurostimulation treatments, has announced a significant market expansion into Canada via an exclusive multi-year distribution deal for their Deep Transcranial Magnetic Stimulation (Deep TMS™) system. The agreement sets out minimum order quantities escalating each year, starting with an initial requirement for 11 systems in 2024. This move aims to address Canada’s mental health crisis by providing a new treatment option for disorders such as major depressive and obsessive-compulsive disorder.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
